TrialClinical breast cancer2020

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Rachel A Freedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.